Humane Genomics

Developer of cancer therapeutics using the oncolytic virus

placeNew York City, New York, United States calendar_todayFounded 2016 groups8 employees language humanegenomics.com

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 33 times.

YearFilings
20212
20222
20232
20242
20252

Investor mix

7 investors on record; lead investors include Y Combinator, Union Square Ventures.

Investor typeCountShare
Venture capital7100%
Coming soon